A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression
about
Fluvoxamine versus other anti-depressive agents for depressionSelective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depressionTreatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs)Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential AnalysisSSRIs versus other antidepressants for depressive disorder.Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.Effects of antidepressant drugs, selective noradrenaline-or 5-hydroxytryptamine uptake inhibitors, on apomorphine-induced hypothermia in mice.Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic reviewEvidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications.Clinical trials of potential antidepressants: to what extent are the elderly represented: a review.Fluvoxamine: clinical trials and clinical use.Fluvoxamine-associated manic behavior: a case series.Inhibition of head twitch response to quipazine in rats by chronic amitriptyline but not fluvoxamine or citalopram.Personality related differences in response to 5-HT uptake inhibition.Meta-analysis of placebo rates in major depressive disorder trials.
P2860
Q24236814-9854D6BD-219C-4257-B6C1-A01434CF1DDDQ24245590-C10463EC-19DB-4B04-BFA4-B3F67C83E1C2Q24245648-5626D890-4AC1-4DBE-8397-9384FD0ED1D2Q28736049-87DD4462-5D67-4934-B423-6340012AC9BAQ33909952-462176B8-C388-4EA2-8D3C-07CE6FE4B35DQ34030056-9D6EF869-EEE0-45DE-9856-7B88D2DE73DBQ34062430-8C64986D-3833-40F7-B646-6E5702090AF8Q34161902-E4B6E774-E6AE-4271-B24C-F92CA049A4ECQ34240696-B876618E-3BAF-407A-B1A8-6B32AD456887Q34534086-9D74C04B-4CC9-4B08-A51B-D34250B0D5C0Q36045554-B4057F33-20EE-493D-AE3D-C69D5CD3594DQ37423102-62FB8ABF-1F9F-4465-A849-0EEFFBECD5C0Q40813439-6632A73A-451E-4C14-8409-FBDC59037A1EQ48413093-93E9A874-70AD-46B4-B6F5-C7119DEBA73EQ51164630-452649AB-7E9C-4C63-8C3A-81E39B9EE974Q51945431-4567B1C7-49D8-4232-8A39-A96D3678CDC7
P2860
A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression
description
1983 nî lūn-bûn
@nan
1983 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
A double-blind placebo-control ...... tients with primary depression
@ast
A double-blind placebo-control ...... tients with primary depression
@en
A double-blind placebo-control ...... tients with primary depression
@nl
type
label
A double-blind placebo-control ...... tients with primary depression
@ast
A double-blind placebo-control ...... tients with primary depression
@en
A double-blind placebo-control ...... tients with primary depression
@nl
prefLabel
A double-blind placebo-control ...... tients with primary depression
@ast
A double-blind placebo-control ...... tients with primary depression
@en
A double-blind placebo-control ...... tients with primary depression
@nl
P2093
P2860
P1476
A double-blind placebo-control ...... tients with primary depression
@en
P2093
Coleman BS
Michael ST
Mukherjee S
Shrivastava RK
P2860
P304
P356
10.1111/J.1365-2125.1983.TB02134.X
P407
P478
15 Suppl 3
P577
1983-01-01T00:00:00Z